WMS Partners’s TELA Bio TELA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-11,495
Closed -$122K 302
2023
Q1
$122K Sell
11,495
-4,310
-27% -$47.5K 0.01% 262
2022
Q4
$182K Hold
15,805
0.02% 254
2022
Q3
$135K Sell
15,805
-12,345
-44% -$102K 0.02% 243
2022
Q2
$197K Hold
28,150
0.03% 234
2022
Q1
$327K Buy
+28,150
New +$341K 0.04% 177
2021
Q4
Sell
-27,300
Closed -$373K 257
2021
Q3
$373K Hold
27,300
0.05% 189
2021
Q2
$440K Hold
27,300
0.07% 155
2021
Q1
$407K Buy
27,300
+11,495
+73% +$173K 0.09% 139
2020
Q4
$238K Buy
+15,805
New +$257K 0.04% 215

Other funds holding TELA

WMS Partners's TELA Position: Q2 2023 in Review

WMS Partners sold out of TELA Bio (TELA) in Q2 2023, closing a stake of 11,495 shares — an estimated $122K sold.

WMS Partners first reported a position in TELA in Q4 2020 and held it in 9 quarters. The position peaked at $440K in Q2 2021. 67 funds tracked by Wall St. Rank hold TELA as of Q2 2023.

  • WMS Partners reported no remaining TELA Bio position as of Q2 2023 after selling out during the quarter.
  • WMS Partners sold 11,495 TELA Bio shares in Q2 2023, an estimated $122K.
  • WMS Partners first reported a position in TELA Bio in Q4 2020 and held it in 9 quarters.
  • WMS Partners's TELA Bio position peaked at $440K in Q2 2021.
  • 67 funds tracked by Wall St. Rank held TELA Bio as of Q2 2023.

Based on WMS Partners's 13F filing for Q2 2023, filed 14 Aug 2023.